Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?

F. Pitoia
  • January 2014, Bioscientifica
  • DOI: 10.1530/ERC-13-0544
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Fabian Pitoia

In partnership with: